# Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin

> **NCT00668850** · PHASE3 · UNKNOWN · sponsor: **Generex Biotechnology Corp.** · enrollment: 500 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Generex Oral-lyn™
- **DRUG:** Regular human insulin

## Key facts

- **NCT ID:** NCT00668850
- **Lead sponsor:** Generex Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2011-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668850, "Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00668850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*